Kiniksa CSO exercises 2,726 RSUs, pays taxes in shares
Kiniksa Pharmaceuticals International, plc chief strategy officer Eben Tessari exercised Restricted Share Units into common shares and had shares withheld for taxes.
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc chief strategy officer Eben Tessari exercised Restricted Share Units into common shares and had shares withheld for taxes. On April 7, 2026, 2,726 RSUs were converted into 2,726 Class A Ordinary Shares. Of these, 846 shares at $48.94 per share were withheld to satisfy tax obligations, leaving Tessari with 23,130 Class A Ordinary Shares held directly. Each RSU represents a right to receive one Class A Ordinary Share and the RSU grant vests in four equal annual installments starting on April 7, 2023, over a four-year period.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Share Unit | 2,726 | $0.00 | $0.00 |
| Exercise | Class A Ordinary Share | 2,726 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Class A Ordinary Share | 846 | $48.94 | $41K |
Footnotes (2)
- F1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
- F2. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022.
Key Figures
Key Terms
tax-withholding disposition financial
Exercise or conversion of derivative security financial
vest over a four-year period financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kiniksa (KNSA) report for Eben Tessari?
What is the size of the RSU exercise reported for Kiniksa (KNSA)?
How were taxes handled in Eben Tessari’s Kiniksa (KNSA) RSU vesting?
How do Tessari’s Kiniksa (KNSA) RSUs vest over time?
AI-generated analysis. How Rhea-AI works. Not financial advice.